February 2011 Archives

February 24, 2011

Drug Labeling Changes for January 2011 (2.23.11)

To view a complete list of drugs requiring revised labels during January 2011,
January 2011 Safety Label Changes

February 22, 2011

Antipsychotic drugs (e.g., Haldol, Risperdal, Ability, Zyprexa, Seroquel) Taken During Pregnancy Increase Risks to Newborns (2.22.11)

The FDA is requiring a label change to the Pregnancy section of all antipsychotic drugs to note potential risk for abnormal muscle movements (extrapyramidal signs or EPS) and withdrawal in newborns whose mothers received these drugs during the third trimester of pregnancy.
Symptoms may include agitation, increased or decreased muscle tone, tremors, sleepiness, significant difficulty breathing, as well as difficulty feeding.

To report an adverse event from antipsychotics:

  • Complete and submit the report Online: MedWatch Online Voluntary Reporting Form (3500)
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and

  • return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178


    February 21, 2011

    Screening and Treating Common Vaginal Infections During Antenatal Care Reduces Preterm Births (2.21.11)

    By providing screening and treatment for common vaginal infections during antenatal care, preterm births were reduced significantly. Reducing the rate of preterm birth through a simple antenatal screen-and-treat programme: a retrospective cohort study.

    February 18, 2011

    Blindness in Premature Infants Possibly Prevented By Cancer Drug (2.18.11)

    The cancer drug, Avastin, has proven to be more effective than laser surgery in treating premature infants who are born before their eyes are fully developed. According to the study, one injection of Avastin into the eyes was more effective than laser treatment.

    STUDY SAYS ROCHE'S AVASTIN COULD PREVENT BLINDNESS IN PREMATURE BABIES

    February 15, 2011

    High-Fiber Grain Diet Extends Life (2.15.11)

    Data show that those consuming over 29 grams of grain fiber daily were 22% less like to succumb to any illness, particularly cardiovascular, infectious and respiratory. Interestingly, fiber from other sources did not result in the same benefits as grain fiber.

    Fiber-Full Diet Lengthens Life

    Primary source: Archives of Internal Medicine
    Source reference:

    Dietary Fiber Intake and Mortality in the NIH-AARP Diet and Health Study

    Additional source: Archives of Internal Medicine
    Source reference:

    Do the Health Benefits of Dietary Fiber Extend Beyond Cardiovascular Disease?

    February 15, 2011

    Berries Reduce Risk of Parkinson's (2.15.11)

    The flavonoid, anthocyamin, found in berries can reduce the risk of Parkinson's by as much as 22%. Researchers found that the more berries consumed the smaller the risk of Parkinson's. AAN:

    Berries Keep Parkinson's at Bay

    Primary source: American Academy of Neurology
    Source reference:
    Gao X, et al "Habitual intake of dietary flavonoids and risk of Parkinson's disease" AAN 2011.

    February 15, 2011

    Elective Delivery Before 39 Weeks Subject to Respiratory Complications Irrespective of Lung Maturity (2.15.11)

    Recent data demonstrate that deliveries before 39 weeks have an increased risk of respiratory issues and other complications despite establishing fetal lung maturity before delivery. SMFM:

    Early Delivery Risky Even for Mature Lungs

    Primary source: Society for Maternal-Fetal Medicine
    Source reference:
    Fang Y, et al "Elective delivery with known fetal lung maturity prior to 39 weeks is still associated with increased neonatal morbidity" Am J Obstet Gynecol 2011; Abstract 58.

    February 14, 2011

    Laughing Gas (Nitrous Oxide) Returning To Labor and Delivery (2.14.11)

    Nitrous oxide fell out of favor in the U.S. several decades ago and was replaced by epidurals (nerve block accomplished by injecting a anesthetic mix into the spinal fluid via the lumbar spine). Recently, however, there is a renewed interest in its use of controlling pain during delivery. Although it is effective in reducing pain, it does not eliminate pain and sensation like epidurals. Nevertheless, it is significantly less expensive and safer than epidurals. Nitrous Oxide for Labor Analgesia

    Laughing Gas For Childbirth: Is It Safe?

    February 11, 2011

    Rupture of Membrane (Amniotomy) Early on During First Delivery Shortens Labor (2.11.11)

    Women who require induction of labor for their first delivery can shorten their labor by two or more hours by undergoing amniotomy early on, according to recent study data.

    SMFM: Early Amniotomy Shortens Labor

    Primary source: Society for Maternal-Fetal Medicine
    Source reference:
    Macones G, et al "The efficiency of early amniotomy in nulliparous labor induction: a randomized controlled trial" Am J Obstet & Gynecol 2011; 204: Abstract 6.

    February 11, 2011

    TPA (Tissue Plasminogen Activator) (Thrombolysis) within First Hour of Stroke Reduces Mortality (2.10.11)

    According to recent study data tPA administered within one hour of an ischemic stroke results in reduced mortality and intracranial hemorrhaging. Additional findings suggest that for every additional quarter-hour delay, there is an additional 5% increased risk of mortality and hemorrhaging. ASA: Earlier tPA in Hospital Saves Lives

    Primary source: Circulation: Journal of the American Heart Association
    Source reference:
    Fonarow GC, et al "Timeliness of tissue plasminogen activator therapy in acute ischemic stroke: Patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes" Circulation 2011.

    February 8, 2011

    New Anticoagulant Dabigatran Degrades 30 Days After Opening Bottle (2.8.11)

    After opening a bottle of Dabigatran it begins to degrade quickly due to humidity in the air. Despite a desiccant (drying agent) built into the bottle cap, the drug will lose its effectiveness 30 days after opening. Use Dabigatran Within 30 Days of Opening

    February 7, 2011

    Makena (hydroxyprogesterone caproate) Approved by FDA to Reduce Preterm-Birth Risk (2.7.11)

    Makena is an injection that is given once a week starting as early as the 16th week of pregnancy but no later than the 21st week. According to study data, Makena resulted in more than a 30% reduction in preterm deliveries. FDA Press Release

    February 7, 2011

    Treating Hemangiomas in Infants with a Beta Blocker/Antihypertensive (2.7.11)

    Recent study data support utilizing Propanol (Inderal) to effectively and safely treat hemangiomas in infants. Because of its promising results, Inderal will likely replace steroid as the drug of choice for treating infants with hemangiomas. PCCD: Beta-Blocker Safe for Hemangiomas
    Primary source: Pediatric and Congenital Cardiovascular Disease meeting

    Source reference:
    Thampan A, et al "Propanolol for infantile hemangiomas: safety and efficacy" PCCD Meeting 2011; Abstract F22.

    February 4, 2011

    Avandia (rosiglitazone) Increases Risk of Cardiovascular Complications (2.4.11)

    Once again the FDA is warning about the cardiovascular risks associate with Avandia and adding an admonition that only patients already treating with Avandia or whose glucose cannot be adequately controlled with other anti-diabetic medications.

    For further information, go to: Avandia (rosiglitazone): REMS - Risk of Cardiovascular Events

    February 3, 2011

    Michigan Hospitals see Improved Patient Safety after Instituting ICU Care-Quality Program (2.3.11)

    After instituting a quality-improvement program in ninety-five Michigan hospitals' ICUs departments patients had a nearly 25% decrease in mortality risks. Improved communications between providers, hand-washing policies, full barrier precautions and avoiding femoral insertion for catheters, were some of the quality processes resulting in the significant improvement of patient safety.

    Primary source: BMJ
    Source reference: Impact of a statewide intensive care unit quality improvement initiative on hospital mortality and length of stay: retrospective comparative analysis

    February 3, 2011

    Avastin (Bevacizumab) Treatment for Cancer Patients Increases Risk of Death (2.2.11)

    Patients who received Avastin during their cancer treatment experienced nearly 50% increased risk of death depending on what type of chemotherapy was utilized in conjunction with Avastin.


    Primary source: Journal of the American Medical Association
    Source reference: Treatment-Related Mortality With Bevacizumab in Cancer Patients

    Additional source: Journal of the American Medical Association
    Source reference: Bevacizumab Treatment for Solid Tumors

    February 1, 2011

    Exercise for Elderly Increases Brain Function (2.1.11)

    Recent study data from Harvard Medical School show that elderly individuals who performed aerobic exercise (e.g., walking) at least three times a week exhibited increased hippocampus volume which in turn resulted in enhanced memory.

    Primary source: Proceedings of the National Academy of Sciences
    Source reference:

    Exercise training increases size of hippocampus and improves memory